Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk

por Behr, Paulo Eduardo Ballvé, Moriguchi, Emilio Hideyuki, Castro, Iran, Bodanese, Luiz Carlos, Dutra, Oscar Pereira, Leães, Paulo Ernesto, Pimentel Filho, Pedro
Publicado 2018